Phase 1 Pharmacokinetic Study of Minoxidil SL Tablets

Inclusion Criteria: * Male and female subjects between 18 and 65 years of age (inclusive) at screening. * In good general health in the opinion of the Investigator based on a medical evaluation including medical history, physical examination, laboratory tests and cardiac monitoring (ECG). A subject with a clinical abnormality or laboratory parameters outside the reference range for the population being studied may be included only if, in the opinion of the Investigator, the finding is (a) unlikely to introduce additional risk to the subject, (b) will not interfere with study procedures or confound study results, and (c) is not listed in the Exclusion Criteria. * Body mass index (BMI) is between 18.5 - 30.0 kg/m2 with a body weight of at least 50 kg. * Have systolic blood pressure within normal limits (90-140 mm Hg). * Have adequate venous access on their left or right arm to allow collection of multiple blood samples. * Women of Childbearing Potential (WOCBP) must agree to use a highly effective method of contraception from enrolment to the safety follow-up visit. * Women of non-childbearing potential must be post-menopausal or permanently sterilised at least 6 months prior to screening. * All WOCBP must have a negative serum pregnancy test at screening and a negative urine pregnancy test before dosing on each dosing day. * Willing and able to attend all study visits and comply with treatment plan and required study procedures. * Able to comprehend and willing to sign and da…